Literature DB >> 3235523

Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography.

S S Good1, D J Reynolds, P de Miranda.   

Abstract

A sensitive high-performance liquid chromatography (HPLC) assay has been developed to simultaneously determine levels of the anti human immunodeficiency virus agent, zidovudine (AZT), and its major metabolite (the 5'-O-glucuronide) in serum. Samples were first mixed with an internal standard (a stereoisomer of AZT), then prepared for analysis using solid-phase extraction columns and chromatographed using a reversed-phase analytical column. Isocratic elution with a mobile phase of 15% acetonitrile, buffered to pH 2.70 with ammonium phosphate, gave good resolution of the three analytes and endogenous serum components. The HPLC analysis time required per sample was 34 min and analyte recoveries were reproducibly high (greater than 93%). Replicate analyses of prepared standards gave satisfactory precision and accuracy, with coefficients of variation less than 15% and deviations from expected concentrations less than 10%.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3235523     DOI: 10.1016/s0378-4347(00)83075-3

Source DB:  PubMed          Journal:  J Chromatogr


  26 in total

1.  Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  Pharmacokinetics of orally administered zidovudine in HIV-infected children and adults.

Authors:  U Wintergerst; B Rolinski; M Vocks-Hauck; V Wahn; K M Debatin; G Notheis; I Grosch-Wörner; F D Goebel; A A Roscher; B H Belohradsky
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

3.  Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.

Authors:  B L Lee; S Safrin; V Makrides; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Drug level monitoring in a double-blind multicenter trial: false-positive zidovudine measurements in AIDS clinical trials group protocol 019.

Authors:  D J Krogstad; M R Eveland; L L Lim; P A Volberding; B M Sadler
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

5.  Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.

Authors:  R G Hewitt; G D Morse; W D Lawrence; M L Maliszewski; J Santora; L Bartos; E Bonnem; B Poiesz
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes.

Authors:  S M Sim; D J Back; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

7.  Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection.

Authors:  G D Morse; A Portmore; J Olson; C Taylor; C Plank; R C Reichman
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

8.  Absorption of zidovudine in patients with diarrhoea.

Authors:  G Zorza; L Beaugerie; A M Taburet; Y Le Quintrec; E Singlas
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.

Authors:  T A Tartaglione; A C Collier; K Opheim; F G Gianola; J Benedetti; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.

Authors:  E Sampol; B Lacarelle; J F Rajaonarison; J Catalin; A Durand
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.